Highlights Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-03-06 am EST			After hours 01:50:02 pm
64.58 ^EUR	-1.64%		64.77	+0.29%

Mar. 05	Moody's Affirms Eurofins Scientific's Ratings, Outlook on Solid Operating Performance in FY25	MT
Feb. 17	CIC Corporate Upgrades Eurofins Scientific to Buy Rating, Boosts PT	MT

Highlights

Feb. 09	Eurofins Viracor BioPharma Expands Bioanalytical Capabilities	CI
Jan. 30	Eurofins, Winfarm, Worldline... Stocks to Watch Today in Paris -
Jan. 29	Eurofins Scientific: Inline results and 2026 outlook; recent re-rating supports our cautious view
Jan. 29	Tranche Update on Eurofins Scientific SE's Equity Buyback Plan announced on April 25, 2025.	CI
Jan. 29	European Stock Markets Awash with Earnings, Rémy Cointreau Shines
Jan. 29	Eurofins Scientific: Preliminary Results and Outlook Hold No Surprises
Jan. 29	Eurofins Scientific SE Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Jan. 29	Eurofins Scientific SE Proposes Annual Dividend	CI
Jan. 29	Eurofins FY revenue at EUR 6.76 bln, confirms 2027 outlook	RE
Jan. 26	Eurofins CDMO Alphora Announces Development & Implementation of AI-Powered Salt and Co-Crystal Screening Software	CI
Jan. 23	Diary - France corporate earnings week ahead	RE
Jan. 05	CAC40 Remains Steady Despite Surprise U.S. Intervention in Venezuela
Jan. 05	Eurofins Scientific, Top Gainer on the CAC 40 at Midday Monday, January 5, 2026
Jan. 05	Paris: Calm Start to the Year on the Stock Market Despite Maduro's Downfall in Venezuela
Jan. 05	CAC40: Slight Uptick as Investors Brush Off Geopolitical Tensions
Dec. 10	The Eurofins Consumer Product Testing Network Completes Significant Laboratory Expansion in Vietnam	CI
Dec. 02	Eurofins Medical Device Services North America Launches First GMP Pfas Screening and Testing Solutions for Medical Devices	CI
25-10-23	AlphaValue/Baader Europe Cuts Eurofins Scientific Rating, Price Target	MT
25-10-23	Berenberg Maintains Eurofins Scientific at Hold Amid Continued BioPharma Segment Headwinds	MT
25-10-21	Eurofins Scientific SE Reports Revenue Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-21	Eurofins Shares Plunge After Disappointing Third Quarter Results	RE
25-10-21	Eurofins Reports 4% Organic Revenue Growth Over Nine Months
25-10-21	Eurofins 9m organic revenue growth at 4.0%	RE
25-09-03	Eurofins Scientific Finalizes Related Party-owned Sites Acquisition	MT
25-07-30	French and Benelux stocks-Factors to watch	RE